# Correction: Dallons et al. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells. Cells 2020, 9, 2177

**Authors:** Matthieu Dallons, Esma Alpan, Corentin Schepkens, Vanessa Tagliatti, Jean-Marie Colet

PMC · DOI: 10.3390/cells14201574 · 2025-10-10

## Full-text entities

- **Diseases:** Breast Cancer (MESH:D001943), Cardiotoxicity (MESH:D066126)
- **Chemicals:** Doxorubicin (MESH:D004317)
- **Cell lines:** MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), H9C2 — Rattus norvegicus (Rat), Spontaneously immortalized cell line (CVCL_0286)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12562507/full.md

---
Source: https://tomesphere.com/paper/PMC12562507